- Home
- MX vs PLRX Comparison
MX vs PLRX Comparison
Compare MX & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | PLRX |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.4M | 81.7M |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MX | PLRX |
|---|---|---|
| Price | $2.87 | $1.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $5.75 | $2.67 |
| AVG Volume (30 Days) | 278.6K | ★ 526.3K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.06 | 29.97 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $178,860,000.00 | N/A |
| Revenue This Year | $8.55 | N/A |
| Revenue Next Year | $6.37 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $1.09 |
| 52 Week High | $4.50 | $1.95 |
Technical Indicators
Market Signals| Indicator | MX | PLRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 56.90 |
| Support Level | $2.56 | $1.12 |
| Resistance Level | $3.02 | $1.39 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 46.95 | 79.25 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.